Results 171 to 180 of about 322,913 (349)

DYSFUNCTION OF PEROXISOMES AS ONE OF POSSIBLE CAUSES OF DEVELOPMENT OF MULTIPLE ORGAN DYSFUNCTION SYNDROME

open access: yesActa Biomedica Scientifica, 2012
The article presents the results of researches of fatty aldehydes and total cholesterol of blood plasma of patients with multiple organ dysfunction syndrome.
A. N. Osipenko   +2 more
doaj  

Effect of intestinal function–recovering decoction on treatment of multiple organ dysfunction syndrome in rats

open access: diamond, 2013
Shu–Jie Zhao   +5 more
openalex   +1 more source

Innovative Metasurface Colorimetric Cell‐on‐a‐Chip Sensor for Continuous, Label‐Free, Non‐Destructive Assessment of Intestinal Barrier Dynamics

open access: yesAdvanced Science, EarlyView.
We developed a real‐time, label‐free, high‐throughput cell‐on‐a‐chip system based on a metasurface plasmon resonance colorimetric sensor (MetaSPRCS) to evaluate intestinal barrier function. This platform enables continuous monitoring of cell adhesion, proliferation, and barrier layer formation, disruption, and repair.
Youqian Chen   +14 more
wiley   +1 more source

Thyrotoxicosis Factitia Leading to Multiple Organ Dysfunction Syndrome [PDF]

open access: gold, 2021
V. Rayasam   +4 more
openalex   +1 more source

Mitochondrial Transplantation as a Therapeutic Strategy for Inherited Mitochondrial Diseases

open access: yesAdvanced Science, EarlyView.
Mitochondrial transplantation (MTx) offers a promising therapeutic avenue for mitochondrial diseases. This review comprehensively evaluates MTx, differentiating its feasibility for mtDNA‐ and nDNA‐based disorders. It examines its potential for genetic correction, alongside inherent limitations, technical challenges, and crucial ethical considerations ...
Parmeshar Singh   +17 more
wiley   +1 more source

The Design of Nested Adaptive Clinical Trials of Multiple Organ Dysfunction Syndrome Children in a Single Study. [PDF]

open access: yesPediatr Crit Care Med, 2023
VanBuren JM   +7 more
europepmc   +1 more source

Combination of Ethoxybenzyl‐Diethylenetriamine Pentaacetic Acid‐Enhanced Magnetic Resonance Imaging and a Serum Biomarker Is Useful in the Diagnosis of Hepatic Sinusoidal Disorder After Chemotherapy Treatment

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy